CareDx Inc Net Income
| CDNA Stock | USD 20.82 0.63 3.12% |
As of the 10th of February, CareDx shows the Downside Deviation of 3.67, mean deviation of 2.95, and Risk Adjusted Performance of 0.1144. CareDx Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
CareDx Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 2.3283 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 47.3 M | 49.7 M | |
| Net Income From Continuing Ops | 47.3 M | 49.7 M | |
| Net Loss | -69 M | -65.5 M | |
| Net Income Per Share | 1.15 | 1.20 | |
| Net Income Per E B T | 0.89 | 0.61 |
CareDx | Net Income | Build AI portfolio with CareDx Stock |
Analyzing CareDx's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing CareDx's current valuation and future prospects.
Latest CareDx's Net Income Growth Pattern
Below is the plot of the Net Income of CareDx Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in CareDx Inc financial statement analysis. It represents the amount of money remaining after all of CareDx Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is CareDx's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CareDx's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 52.55 M | 10 Years Trend |
|
Net Income |
| Timeline |
CareDx Net Income Regression Statistics
| Arithmetic Mean | (21,298,711) | |
| Coefficient Of Variation | (264.30) | |
| Mean Deviation | 36,721,179 | |
| Median | (13,707,000) | |
| Standard Deviation | 56,292,429 | |
| Sample Variance | 3168.8T | |
| Range | 242.8M | |
| R-Value | (0.02) | |
| Mean Square Error | 3379.3T | |
| R-Squared | 0.0002 | |
| Significance | 0.95 | |
| Slope | (169,799) | |
| Total Sum of Squares | 50701.4T |
CareDx Net Income History
Other Fundumenentals of CareDx Inc
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
CareDx Net Income component correlations
CareDx Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for CareDx is extremely important. It helps to project a fair market value of CareDx Stock properly, considering its historical fundamentals such as Net Income. Since CareDx's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CareDx's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CareDx's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CareDx. Projected growth potential of CareDx fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CareDx assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 1.28 | Revenue Per Share | Quarterly Revenue Growth 0.207 | Return On Assets | Return On Equity |
Understanding CareDx Inc requires distinguishing between market price and book value, where the latter reflects CareDx's accounting equity. The concept of intrinsic value - what CareDx's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push CareDx's price substantially above or below its fundamental value.
It's important to distinguish between CareDx's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CareDx should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, CareDx's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
CareDx 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CareDx's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CareDx.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in CareDx on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding CareDx Inc or generate 0.0% return on investment in CareDx over 90 days. CareDx is related to or competes with Personalis, Myriad Genetics, Castle Biosciences, Embecta Corp, Fulgent Genetics, Evolent Health, and DarioHealth Corp. CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwi... More
CareDx Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CareDx's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CareDx Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.67 | |||
| Information Ratio | 0.1106 | |||
| Maximum Drawdown | 28.32 | |||
| Value At Risk | (5.05) | |||
| Potential Upside | 8.08 |
CareDx Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CareDx's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CareDx's standard deviation. In reality, there are many statistical measures that can use CareDx historical prices to predict the future CareDx's volatility.| Risk Adjusted Performance | 0.1144 | |||
| Jensen Alpha | 0.4417 | |||
| Total Risk Alpha | 0.0905 | |||
| Sortino Ratio | 0.1359 | |||
| Treynor Ratio | 0.3572 |
CareDx February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1144 | |||
| Market Risk Adjusted Performance | 0.3672 | |||
| Mean Deviation | 2.95 | |||
| Semi Deviation | 3.24 | |||
| Downside Deviation | 3.67 | |||
| Coefficient Of Variation | 755.04 | |||
| Standard Deviation | 4.51 | |||
| Variance | 20.3 | |||
| Information Ratio | 0.1106 | |||
| Jensen Alpha | 0.4417 | |||
| Total Risk Alpha | 0.0905 | |||
| Sortino Ratio | 0.1359 | |||
| Treynor Ratio | 0.3572 | |||
| Maximum Drawdown | 28.32 | |||
| Value At Risk | (5.05) | |||
| Potential Upside | 8.08 | |||
| Downside Variance | 13.45 | |||
| Semi Variance | 10.49 | |||
| Expected Short fall | (3.36) | |||
| Skewness | 1.41 | |||
| Kurtosis | 5.58 |
CareDx Inc Backtested Returns
CareDx appears to be not too volatile, given 3 months investment horizon. CareDx Inc secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for CareDx Inc, which you can use to evaluate the volatility of the firm. Please makes use of CareDx's Downside Deviation of 3.67, mean deviation of 2.95, and Risk Adjusted Performance of 0.1144 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, CareDx holds a performance score of 8. The firm shows a Beta (market volatility) of 1.64, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CareDx will likely underperform. Please check CareDx's value at risk, expected short fall, and the relationship between the treynor ratio and downside variance , to make a quick decision on whether CareDx's price patterns will revert.
Auto-correlation | 0.48 |
Average predictability
CareDx Inc has average predictability. Overlapping area represents the amount of predictability between CareDx time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CareDx Inc price movement. The serial correlation of 0.48 indicates that about 48.0% of current CareDx price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.48 | |
| Spearman Rank Test | 0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 1.05 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
CareDx Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, CareDx Inc reported net income of 52.55 M. This is 84.6% lower than that of the Biotechnology sector and 69.64% lower than that of the Health Care industry. The net income for all United States stocks is 90.8% higher than that of the company.
CareDx Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CareDx's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CareDx could also be used in its relative valuation, which is a method of valuing CareDx by comparing valuation metrics of similar companies.CareDx is currently under evaluation in net income category among its peers.
CareDx Current Valuation Drivers
We derive many important indicators used in calculating different scores of CareDx from analyzing CareDx's financial statements. These drivers represent accounts that assess CareDx's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of CareDx's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 909.2M | 3.4B | 2.4B | 608.4M | 547.6M | 686.5M | |
| Enterprise Value | 876.4M | 3.3B | 2.0B | 557.5M | 501.7M | 786.6M |
CareDx ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, CareDx's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CareDx's managers, analysts, and investors.Environmental | Governance | Social |
CareDx Institutional Holders
Institutional Holdings refers to the ownership stake in CareDx that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of CareDx's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing CareDx's value.| Shares | Amova Asset Management Americas, Inc | 2025-06-30 | 1.2 M | Fred Alger Management, Llc | 2025-06-30 | 1.2 M | Renaissance Technologies Corp | 2025-06-30 | 1.2 M | Goldman Sachs Group Inc | 2025-06-30 | 1.1 M | Next Century Growth Investors Llc | 2025-06-30 | 1.1 M | Jacobs Levy Equity Management, Inc. | 2025-06-30 | 1.1 M | Connor Clark & Lunn Inv Mgmt Ltd | 2025-06-30 | 1.1 M | Dimensional Fund Advisors, Inc. | 2025-06-30 | 962.8 K | Citadel Advisors Llc | 2025-06-30 | 790.7 K | Vanguard Group Inc | 2025-06-30 | 4.9 M | Blackrock Inc | 2025-06-30 | 4.7 M |
CareDx Fundamentals
| Return On Equity | 0.24 | ||||
| Return On Asset | -0.0401 | ||||
| Profit Margin | 0.20 % | ||||
| Operating Margin | (0) % | ||||
| Current Valuation | 833.53 M | ||||
| Shares Outstanding | 51.43 M | ||||
| Shares Owned By Insiders | 4.40 % | ||||
| Shares Owned By Institutions | 95.60 % | ||||
| Number Of Shares Shorted | 5.58 M | ||||
| Price To Earning | (4.25) X | ||||
| Price To Book | 3.21 X | ||||
| Price To Sales | 2.89 X | ||||
| Revenue | 333.79 M | ||||
| Gross Profit | 242.15 M | ||||
| EBITDA | (33.99 M) | ||||
| Net Income | 52.55 M | ||||
| Cash And Equivalents | 306.22 M | ||||
| Cash Per Share | 5.73 X | ||||
| Total Debt | 28.37 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 5.15 X | ||||
| Book Value Per Share | 6.05 X | ||||
| Cash Flow From Operations | 38.05 M | ||||
| Short Ratio | 7.21 X | ||||
| Earnings Per Share | 1.28 X | ||||
| Price To Earnings To Growth | (0.12) X | ||||
| Target Price | 22.0 | ||||
| Number Of Employees | 644 | ||||
| Beta | 2.51 | ||||
| Market Capitalization | 1.04 B | ||||
| Total Asset | 491.05 M | ||||
| Retained Earnings | (626.24 M) | ||||
| Working Capital | 262.46 M | ||||
| Current Asset | 34.36 M | ||||
| Current Liabilities | 10.15 M | ||||
| Net Asset | 491.05 M |
About CareDx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CareDx Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CareDx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CareDx Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CareDx Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CareDx's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caredx Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caredx Inc Stock:Check out You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CareDx. Projected growth potential of CareDx fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CareDx assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 1.28 | Revenue Per Share | Quarterly Revenue Growth 0.207 | Return On Assets | Return On Equity |
Understanding CareDx Inc requires distinguishing between market price and book value, where the latter reflects CareDx's accounting equity. The concept of intrinsic value - what CareDx's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push CareDx's price substantially above or below its fundamental value.
It's important to distinguish between CareDx's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CareDx should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, CareDx's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.